secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pediatrix Medical Group, Inc. (MD)
CIK:        0000893949
Form:       8-K
Filed at:   2025-08-05T23:59:59+00:00
Accession:  0000950170-25-102375
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pediatrix Q2 EPS $0.46, Adjusted $0.53; raises FY 2025 EBITDA guidance to $245-255M
--------------------------------------------------------------------------------

- Net revenue $469M; net income $39M vs. loss of $153M a year ago due to non-cash impairment.
- Adjusted EBITDA $73M, up from $58M in Q2 2024; raised FY guidance to $245-255M (from $220-240M).
- Same-unit revenue +6.4% with neonatology NICU days up 6.0% year-over-year.
- Cash from continuing operations $138M; total debt $606M; no revolver borrowings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/893949/000095017025102375/0000950170-25-102375-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/893949/000095017025102375/md-20250805.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-102375

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer